Last reviewed · How we verify
NCT06272617
Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
NA trial testing verum acupuncture in Malignant Tumor of Head and/or Neck in 138 participants. Status unknown.
24 July 2024
Quick facts
| Lead sponsor | West China Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 138 |
| Start date | 25 July 2023 |
| Primary completion | 24 July 2024 |
| Estimated completion | 24 July 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- verum acupuncture
- sham acupuncture
Conditions studied
- Malignant Tumor of Head and/or Neck — all drugs for Malignant Tumor of Head and/or Neck →
- Radiotherapy; Complications — all drugs for Radiotherapy; Complications →
Sponsor
West China Hospital
Who can join
Adults 18 to 80, any sex, with Malignant Tumor of Head and/or Neck or Radiotherapy; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A study on the efficacy and safety of acupuncture for the prevention and treatment of oral-related complications caused by radiotherapy for head and neck malignant tumors
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06272617
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of verum acupuncture
Trials testing the same drug.
- NCT05406830 — Efficacy Study of Acupuncture on Asymptomatic Hyperuricemia · NA · unknown
- NCT03716830 — Enhancing Acupuncture Treatment Effect Through Non-invasive Neuromodulation · NA · completed
Other recruiting trials for Malignant Tumor of Head and/or Neck
Currently open trials in the same condition.
- NCT05421507 — 3D-PCT Combined With CT-guided Radioactive I-125 Seed Implantation in the Treatment of Head and Neck Tumors · recruiting
Other West China Hospital trials
Trials by the same sponsor.
- NCT07583654 — Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
- NCT07583914 — Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
- NCT07492914 — Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma · Phase 2 · recruiting
- NCT07507097 — Study on the Optimal Head Position for Patients With Severe Acute Ischemic Stroke · NA · not yet recruiting
- NCT07472933 — Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06272617 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by West China Hospital
- Last refreshed: 22 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06272617.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing